本页面由Tiger Trade Technology Pte. Ltd.提供服务

梯瓦制药

33.92
+0.01000.03%
盘后33.930.0100+0.03%18:32 EST
成交量:296.60万
成交额:1.01亿
市值:395.17亿
市盈率:28.03
高:34.22
开:33.69
低:33.52
收:33.91
52周最高:37.35
52周最低:12.47
股本:11.65亿
流通股本:11.42亿
量比:0.40
换手率:0.26%
股息:- -
股息率:- -
每股收益(TTM):1.21
每股收益(LYR):1.21
净资产收益率:20.79%
总资产收益率:6.17%
市净率:5.00
市盈率(LYR):28.03

数据加载中...

公司资料

公司名字:
梯瓦制药
交易所:
NYSE
成立时间:
1901
员工人数:
32008
公司地址:
124 Dvora HaNevi’a St.,Tel Aviv-Yafo,Israel
邮编:
6944020
传真:
- -
简介:
Teva Pharmaceutical Industries Limited于1944年2月13日在以色列注册成立。该公司是一家全球性生物制药公司,拥有重要的仿制药业务,在全球约57个市场开展业务。它专注于神经科学和免疫学领域的创新,同时提供复杂的仿制药、生物仿制药和药房品牌,以满足患者的需求。

董事

名称
职位
Kare Schultz
Director and President and Chief Executive Officer
Sol J. Barer
Chairman of the Board of Directors
Amir Elstein
董事
Dan S. Suesskind
董事
Gabrielle Sulzberger
董事
Galia Maor
董事
Gerald M. Lieberman
董事
Jean Michel Halfon
董事
Murray Goldberg
董事
Nechemia J. Peres
董事
Perry D. Nisen
董事
Roberto A. Mignone
董事
Rosemary A. Crane
董事

股东

名称
职位
Kare Schultz
Director and President and Chief Executive Officer
Michael McClellan
Executive Vice President, Chief Financial Officer
Brendan O'Grady
Executive Vice President, North America Commercial
Carlo de Notaristefani
Executive Vice President, Global Operations
David M. Stark
Executive Vice President, Chief Legal Officer
Gianfranco Nazzi
Executive Vice President, Growth Markets Commercial
Hafrun Fridriksdottir
Executive Vice President, Global R&D
Iris Beck Codner
Executive Vice President, Global Brand and Communications
Mark Sabag
Executive Vice President, Global Human Resources
Richard Daniell
Executive Vice President, European Commercial
Sven Dethlefs
Executive Vice President, Global Marketing & Portfolio